TO EVALUATE THE EFFICACY OF MASHA MASHAPARNYADI CHURNA AFTER VIRECHANA KARMA IN KSHEENA SHUKRA WITH SPECIAL REFERENCE TO OLIGOZOOSPERMIA AND ITS COMPARISION WITH ASHWAGANDHA CHURNA AFTER VIRECHANA KARMA

TO EVALUATE THE EFFICACY OF MASHA MASHAPARNYADI CHURNA AFTER VIRECHANA KARMA IN KSHEENA SHUKRA WITH SPECIAL REFERENCE TO OLIGOZOOSPERMIA AND ITS COMPARISION WITH ASHWAGANDHA CHURNA AFTER VIRECHANA KARMA -A RANDOMIZED OPEN LABELLED COMPARATIVE CLINICAL STUDY - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104571

Enrollment

Registered

2026-02-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects between the age group of 22 to 50 years. Subjects Diagnosed with Oligozoospermia (range we considered is sperm count 1- 15million/ml). Subjects fit for Virechana karma. Subject who are willing to give informed consent.

Exclusion criteria

Exclusion criteria: Subjects diagnosed with asthenospermia, azoospermia and teratospermia. Subjects diagnosed with Sexually transmitted diseases. Subjects diagnosed with Genetic disorders like klinfelters syndrome. Subject diagnosed with varicocele,accessory sex gland infection. Subjects diagnosed with severe uncontrolled systemic disorders which might interfere in the course of disease and treatment.

Design outcomes

Primary

Measure	Time frame
1.Assesement of Significant Changes will be made on the basis of grading and scoring of Subjective Parameters like Erection,Perfomance Anxiety, Penile Rigidity,Ejaculation and Objective Parameters like Sperm count on 0th day and 76th day. 2.Establishment of Clinical Efficacy of administration of Mashamashaparnyadi churna with Virechana in Ksheena Shukra.Timepoint: Group A- Virechana followed by Administarion of Masha mashaparnyadi churna(intervention group) Group B-Virechana followed by ashwagandha churna (comparitive group) Trial period -75 days Total study duration -75 days	—

Measure

Time frame

1.Assesement of Significant Changes will be made on the basis of grading and scoring of Subjective Parameters like Erection,Perfomance Anxiety, Penile Rigidity,Ejaculation and Objective Parameters like Sperm count on 0th day and 76th day. 2.Establishment of Clinical Efficacy of administration of Mashamashaparnyadi churna with Virechana in Ksheena Shukra.Timepoint: Group A- Virechana followed by Administarion of Masha mashaparnyadi churna(intervention group) Group B-Virechana followed by ashwagandha churna (comparitive group) Trial period -75 days Total study duration -75 days

—

Secondary

Measure	Time frame
1.Generation of data on Significant changes observed in the grading & scoring in Subjective & Objective parameters. 2.Generation of data on possible unexpected or adverse drug reactions or events. 3. Generation in depth ananlysis data on different aspect of the diseaseTimepoint: Group A- Virechana followed by Administarion of Masha mashaparnyadi churna(intervention group) Group B-Virechana followed by ashwagandha churna (comparitive group) Trial period -75 days Total study duration -75 days	—

Measure

Time frame

1.Generation of data on Significant changes observed in the grading & scoring in Subjective & Objective parameters. 2.Generation of data on possible unexpected or adverse drug reactions or events. 3. Generation in depth ananlysis data on different aspect of the diseaseTimepoint: Group A- Virechana followed by Administarion of Masha mashaparnyadi churna(intervention group) Group B-Virechana followed by ashwagandha churna (comparitive group) Trial period -75 days Total study duration -75 days

—

Countries

India

Contacts

Public ContactDr Arif khan

Sri Sri College Of Ayurvedic Science And Research Hospital

drarifkhansonofjs@gmail.com7676806222

Outcome results